Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Bayer

Bayer's CEO cut manager ranks by 70%. Now comes the hard part

Also: All the news and watercooler chat from Fortune.

Fortune · Oct 7

Donald Trump High-Dose Aspirin Claims: Experts Examine Risks and National Drug Code Identifiers

Donald Trump's unexplained '386' aspirin remark renews scrutiny of his documented daily regimen and the medical guidance around aspirin use.

International Business Times UK · Oct 5

Donald Trump Reportedly Admits Taking Daily Preventative Medication Amid Ongoing Health Concerns

Donald Trump said his daily aspirin use is partly psychological as earlier medical records confirm a 325mg dose and lower-dose advice.

International Business Times UK · Oct 4

From analysis to the latest developments in health,
read the most diverse news in one place.

Germany's Bayer to invest $2.2 billion in US pharma site

Bayer has announced a significant investment of $2.2 billion to establish a new pharmaceutical site in New Albany, Ohio. This project follows over $7 billion in investments by Bayer in US pharmaceutical research and development. The facility aims to focus on critical areas including cancer, heart, and kidney care. It…

The Economic Times · Oct 3

Farmers unite worldwide against what they call ‘chemical colonisation’

Farmers and activists around the world are mobilising on Saturday for an international day of action against pesticides – denouncing products sold by major agrochemical companies that they say are damaging their health and destroying their livelihoods.

Radio France Internationale · Oct 2

Nonhormonal Hot Flash Pill Lynkuet Gets FDA Priority Review for Breast Cancer Patients on Hormone Therapy

The FDA granted priority review to Lynkuet for hot flashes caused by breast cancer endocrine therapy. Here is what the OASIS-4 trial showed.

Medical Daily · Oct 1

US environment agency let Bayer pick regulations for destructive weedkiller, documents show

Environmental Protection Agency asked firm to choose rules it wanted for dicamba, then put the choices in a proposed federal rule

The Guardian - US · Sep 20

Read news from The Economist, FT, and more,
with one subscription

Even Undiagnosed Roundup Users Would Be Covered by the $7.25 Billion Lymphoma Settlement a Judge Weighs Monday

A St. Louis judge weighs Bayer's $7.25 billion Roundup lymphoma deal Monday. It covers people not yet diagnosed. What exposed families should know.

Medical Daily · Sep 12

Lung Cancer Patients With HER2 Mutations Can Now Start a Daily Targeted Pill Before Any Other Systemic Treatment

The FDA expanded sevabertinib, sold as Hyrnuo, to first-line use for HER2-mutant lung cancer. Who qualifies, trial results, and key side effects.

Medical Daily · Sep 11

Bayer COO: we stopped assigning sales targets. Our teams aimed higher

With a big redesign, will people still give their best? The answer depends on what you believe about your people.

Fortune · Sep 10

Four firms control more than half of the world's seed supply. Italian farmers are fighting back and returning to the bartering system

Bayer, Corteva, Syngenta, and BASF dominate the global seed market. Growers in Italy are saving and trading seeds outside that system.

Fortune · Aug 25

Senate Committee Rejects Amendment That Would Have Expanded Pesticide Liability Nationwide

Senate Agriculture Committee Republicans voted down an amendment restoring failure-to-warn lawsuits against pesticide manufacturers.

Medical Daily · Aug 10

In 1897, a German chemist while trying to ease his father’s rheumatic pains accidently developed a drug still widely used as an over-the-counter medication around the world: How did Felix Hoffmann invented Aspirin?

In 1897, a German chemist while trying to ease his father’s rheumatic pains accidentally developed a drug still widely used as an over-the-counter medication around the world. Felix Hoffmann synthesized acetylsalicylic acid at Bayer, creating aspirin. The same chemist also synthesized heroin during the same period. The story of aspirin…

The Economic Times · Aug 8

Global Market: European shares edge higher as earnings offset Middle East concerns; Lufthansa, Zalando slide

European shares saw modest gains as investors reviewed corporate earnings reports. Energy stocks edged higher while oil prices rebounded from recent declines. Travel and leisure shares slipped as higher fuel costs posed concerns. Lufthansa and Zalando shares fell significantly after their earnings updates. Bayer shares rose after reporting a surprise…

The Economic Times · Aug 4

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune · Jul 9

Farm groups saved Bayer in court over RoundUp cancer claims. Five days later, Bayer called for tariffs on the ingredient farmers rely on

A tariff petition on Chinese glyphosate, a key RoundUp ingredient, has turned Bayer's biggest legal allies into its loudest critics

The Conversation · Jul 6

NZ’s approval of Roundup relies on industry-funded reviews currently under investigation

Last month’s US Supreme Court ruling in favour of the makers of the weedkiller Roundup (formerly Monsanto, now owned by German pharmaceuticals group Bayer) upended thousands of lawsuits based on the cancer risk associated with the product’s active ingredient glyphosate.

France 24 · Jun 25

US Supreme Court sides with Bayer, blocking thousands of cancer lawsuits against popular weedkiller

The US Supreme Court on Thursday sided with Bayer in a ruling expected to block thousands of lawsuits claiming its Roundup weedkiller caused cancer by failing to carry adequate warning labels. The decision hands a victory to President Donald Trump's administration but drew backlash from allies in the "Make America…

The Independent UK · Jun 25

Supreme Court sides with Roundup weedkiller maker in battle over cancer warning

The case before the court was filed by a Missouri resident who developed cancer after more than 20 years of serving as a neighborhood ‘spray guy’

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US · Jun 25

US supreme court blocks thousands of lawsuits over Roundup maker’s pesticide warning labels

The case, Monsanto v Durnell, specifically dealt with claims that the company failed to warn users of product risks

The Independent UK · Jun 25

Supreme Court ruling blocks thousands of lawsuits against maker of Roundup weedkiller

The Supreme Court has sided with the maker of Roundup weedkiller, blocking thousands of lawsuits alleging it failed to warn users the product could cause cancer

MarketBeat · Jun 4

AbCellera Biologics Bets on Hot Flash Antibody as Pipeline Pivot Gains Steam

AbCellera Biologics (NASDAQ:ABCL) is emphasizing its transition from a partner-based antibody discovery business to a proprietary drug development company, Chief Financial Officer Andrew Booth said during a company presentation focused on the biotech’s pipeline and lead clinical program. Booth said

The Independent UK · May 22

Legal fight could delay a proposed $7B settlement for lawsuits in Roundup cancer claims

A proposed $7.25 billion settlement over claims that Roundup weedkiller causes cancer now faces potential delays

MarketBeat · May 14

Bayer Aktiengesellschaft Backs Crop Science Targets as Seed Pipeline Gains Momentum

Bayer Aktiengesellschaft (ETR:BAYN) executives said the company’s Crop Science division remains on track with a five-year plan centered on cost savings, margin expansion and a slate of product launches in seeds, traits and crop protection. Speaking at a BMO Capital Markets event, Rodrigo Santos, Pr

The Economic Times · May 13

Bayer strengthens its phygital connect with Indian farmers as FarmRise app reaches 5 million users

The initiative also includes digital marketplaces, satellite-based insights for risk protection, and AI-powered advisory, aiming to enhance farmer decision-making and sustainability.

MarketBeat · May 12

Bayer Aktiengesellschaft Q1 Earnings Call Highlights

Bayer Aktiengesellschaft (ETR:BAYN) said its first-quarter results for 2026 were in line with expectations, with group sales rising 4% on a currency- and portfolio-adjusted basis to EUR 13.4 billion and core earnings per share increasing to EUR 2.71. Bill, speaking for Bayer management on the call,

1 2 3 4 5

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Center for Biological Diversity

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.